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Abstract: Chlamydia trachomatis and Waddlia chondrophila are strict intracellular bacteria belonging
to the Chlamydiales order. C. trachomatis is the most frequent bacterial cause of genital and ocular
infections whereas W. chondrophila is an opportunistic pathogen associated with adverse pregnancy
outcomes and respiratory infections. Being strictly intracellular, these bacteria are engaged in a
complex interplay with their hosts to modulate their environment and create optimal conditions
for completing their life cycle. For this purpose, they possess several secretion pathways and, in
particular, a Type III Secretion System (T3SS) devoted to the delivery of effector proteins in the host
cell cytosol. Identifying these effectors is a crucial step in understanding the molecular basis of
bacterial pathogenesis. Following incubation of infected cells with perfringolysin O, a pore-forming
toxin that binds cholesterol present in plasma membranes, we analysed by mass spectrometry
the protein content of the host cell cytoplasm. We identified 13 putative effectors secreted by C.
trachomatis and 19 secreted by W. chondrophila. Using Y. enterocolitica as a heterologous expression
and secretion system, we confirmed that four of these identified proteins are secreted by the T3SS.
Two W. chondrophila T3SS effectors (hypothetical proteins Wcw_0499 and Wcw_1706) were further
characterised and demonstrated to be early/mid-cycle effectors. In addition, Wcw_1706 is associated
with a tetratricopeptide domain-containing protein homologous to C. trachomatis class II chaperone.
Furthermore, we identified a novel C. trachomatis effector, CT460 that localises in the eukaryotic
nucleus when ectopically expressed in 293 T cells.
Keywords: Chlamydia trachomatis; Waddlia chondrophila; Type III Secretion System; effectors;
perfringolysin O; selective permeabilisation; host-pathogen interactions; virulence factors;
nuclear effector
1. Introduction
Chlamydia trachomatis is an important human pathogen responsible for genital tract or ocular
infections that affect millions of people worldwide and can lead to infertility or blindness, depending on
the different serovars [1,2]. Waddlia chondrophila is an emerging human and animal bacterial pathogen.
In humans, its association with adverse pregnancy outcomes was documented on multiple occasions
in the past ten years [3–8] and its implication in respiratory infections was also suggested [9,10].
W. chondrophila was isolated twice from an aborted bovine foetus and since then was reported to
be a bovine abortigenic agent in several studies [10–15]. Consistent with its pathogenic potential,
W. chondrophila is able to infect and propagate in human macrophages, the first line of defence against
infection, as well as in endometrial cells and pneumocytes [16,17].
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C. trachomatis and W. chondrophila both belong to the Chlamydiales order, a phylum that encompasses
strict intracellular bacteria that are important human and animal pathogens as well as environmental or
symbiotic organisms [18]. They share with all other members of the phylum a biphasic developmental
cycle that involves two morphologically distinct forms, an extracellular infectious Elementary Body
(EB) and an intracellular replicative Reticulate Body (RB). Inside their host cell, bacteria reside and
multiply in a vacuole called inclusion (reviewed in [19]).
Like other intracellular bacteria, Chlamydiales need to communicate and interact closely with their
host cells in order to promote bacterial survival and establish a favourable environment to support
their replication. For this purpose, they secrete proteins, called effectors, into the inclusion lumen and
within their host cell cytosol. Chlamydial genomes encode several essential protein secretion systems
such as the Sec system, which delivers proteins in the periplasmic space and can be coupled to Type II
or Type V Secretion Systems for translocation in the lumen of the inclusion. Chlamydiales also possess a
Type III Secretion System (T3SS) that spans the inclusion membrane and allows direct secretion into
the host cell cytosol [20]. Structural components of the T3SS apparatus and chaperones required for
maintenance of the effectors in a secretion-competent state are very well conserved between all known
members of the Chlamydiales order [18]. Effector proteins however are largely species-specific and
likely contribute towards the differences in the host specificity and intracellular trafficking observed
between the various members of this phylum [20,21]. Indeed, while C. trachomatis replication is mainly
restricted to mammalian cells [22,23], W. chondrophila is able to multiply in a broad range of hosts
including protists, insect, fish and mammalian cell lines [17,24,25]. Furthermore, these two bacterial
species display different trafficking after internalisation within their host cell. W. chondrophila recruits
mitochondria around the replicative vacuole whereas C. trachomatis disrupts the host cell Golgi and
obtains lipids by intercepting vesicular traffic to the plasma membrane [16,26,27]. Both of them are
able to escape endocytic pathway and exhibit a close contact between endoplasmic reticulum and the
inclusion membrane [16,28].
Chlamydial T3SS effectors are divided in two subsets: (i) soluble effectors secreted within host
cytosol, and (ii) effectors translocated and inserted in the inclusion membrane, also called Incs (reviewed
in [20]). The latter share a specific feature, a hydrophobic bilobed domain that inserts the protein
within the inclusion membrane, leaving the amino and carboxyl termini accessible on the host cell
cytosol side (reviewed in [19]). T3SS effectors display very poor sequence homologies, making them
difficult to identify, and even if C. trachomatis Incs have been widely studied, virtually nothing is known
about Incs secreted by W. chondrophila, as well as about soluble effectors secreted by both bacteria.
Effector secretion is an active process with an effective cost for the bacteria. This implies that every
secreted protein has an important function and plays an essential role in bacterial entry, survival or
replication. Identifying those secreted effectors is a crucial step in understanding the molecular bases
of chlamydial pathogenesis.
In the present work, we use a selective permeabilisation method to create pores in the eukaryotic
plasma membrane of infected cells without disrupting the inclusion membrane. We submit the
released cytosolic content of infected cells to mass spectrometry to identify proteins of C. trachomatis
and W. chondrophila secreted during infection. Among the identified proteins is the Chlamydial
Protease-like Activity Factor (CPAF), a well-described secreted protein. Two of the proteins secreted by
C. trachomatis were ectopically expressed in 293T cells and their subcellular localisation is assessed by
immunofluorescence. In addition, two W. chondrophila secreted proteins are further characterised with
respect to their temporal expression and sub-cellular localization during the course of an infection in
Vero cells.
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2. Materials and Methods
2.1. Cell Culture and Bacterial Strains
Vero, McCoy, HEp-2 and HEK 293T cells (ATCC CCL-81, ECACC 90010305, ATCC CCL-23 and
ATCC CRL-3216) were grown at 37 ◦C, 5% CO2 in high glucose Dulbecco’s modified minimal essential
medium (DMEM, PAN Biotech, Aidenbach, Germany) supplemented with 10% fetal calf serum (Gibco,
Thermo Fisher Scientific, Waltham, MA, USA). Waddlia chondrophila strain ATCC VR-1470 was grown
at 32 ◦C within Acanthamoeba castellanii strain ATCC 30,010 as described elsewhere [29]. Chlamydia
trachomatis strain UW-3/Cx Serovar D (ATCC VR-885) was grown in McCoy cells as described in
ATCC protocols.
2.2. W. chondrophila Infection Procedure
Vero cells were seeded at 2.5 × 105 cells per well in 24-wells microplates for immunofluorescence
or at 4 × 106 cells per 25 cm2 flasks for RNA extraction or total protein preparation. Cells were
infected the following day with a 1/2000 dilution of W. chondrophila recovered from a 4 day-old amoebal
co-culture and filtered through a 5 µm filter (Millipore, Carrigtwohill, Ireland) to eliminate amoebal
trophozoites and cysts. This bacterial dilution corresponds to an MOI of 2–3, as estimated with a
W. chondrophila specific real time quantitative PCR [9]. The infection procedure was performed as
described in Kebbi-Beghdadi et al. [25].
2.3. C. trachomatis Infection Procedure
For PFO experiments, C. trachomatis were grown during 6 days in McCoy cells and recovered by
scraping the flask and filtering the lysate through a 5 µm filter. HEp2 cells were infected at an MOI
of 10 by centrifuging cells and bacteria during 10 min at 1790 g followed by a 15 min incubation at
37 ◦C. Infected cells were washed 3 times with PBS and further incubated at 37 ◦C, 5% CO2 in DMEM
10% FCS.
2.4. Selective Permeabilisation with Perfringolysin o and Mass Spectrometry Analysis
HEp-2 cells were seeded one day prior to infection in 6-wells microplates at 2 × 106 cells per well
and infected with W. chondrophila (MOI 10) or C. trachomatis (MOI 10) as described above. Twenty-four
hours after infection, plates were cooled down on ice during 10 min, washed 3 times with PBS and
incubated during 10 min at 4 ◦C with 100 nM perfringolysin O purified from E. coli [30,31] in RPMI
medium without phenol red. After three more washes with cold PBS, cells were incubated during
30 min at 37 ◦C, 5% CO2 in 1 mL of RPMI without phenol red medium. Culture supernatant was
collected and centrifuged during 3 min at 12,500 g before being analysed by shotgun mass spectrometry
at the Protein Analysis Facility (PAF) of Lausanne University. Results were analysed by the Facility
using the MASCOT software.
2.5. Yersinia enterocolitica Type III Secretion Assays
Y. enterocolitica HOPEMT (T3SS-proficient) and HOPEMT YscU (T3SS-deficient) strains were used
to assess T3SS-dependent secretion, as described in da Cunha et al. [32]. Briefly, full-length genes tagged
with a C-terminal V5 epitope were cloned in pLJM3 under control of the yop promoter and transformed
in the two Y. enterocolitica strains. The E. coli β lactamase TEM1 gene lacking its predicted N-terminal
signal peptide (aa 1–23) was cloned in pLJM3 without a V5 epitope. Bacteria were grown with shaking
(200 rpm) in BHI medium supplemented with 20 mM sodium oxalate, 0.4% glucose and 20 mM MgCl2
first during 2 h at 27 ◦C and then at 37 ◦C in a water bath. This temperature shift activates the yop
regulon and promotes the secretion of T3SS effectors. After 4 h of growth at 37 ◦C, absorbance of the
culture was measured at OD600 and bacteria were pelleted by 1 min centrifugation at 18,000 g. Culture
supernatants were precipitated over night at 4 ◦C with trichloroacetic acid. The pelleted proteins
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from the supernatant were washed with acetone and resuspended in SDS loading buffer. Bacterial
pellets were resuspended in SDS loading buffer immediately after centrifugation. Both fractions were
normalised according to their OD600 values and analysed by SDS-PAGE and immunoblotting
Type III-dependent secretion of Wcw_1706 was also assessed using the Y. enterocolitica MRS40
(pNG40031) strain as described in [33].
2.6. Ectopic Expression in HEK 293T Cells
HEK 293 T cells were seeded on glass coverslips at 1 × 105 cells per well in 24-well microplates.
The following day, cells were transfected with pDEST47_CT460/CT432/EfTu or pDEST53 (GFP alone)
using Lipofectamine 3000 Reagent (Thermo Fisher Scientific, Waltham, MA, USA) following the
manufacturer’s instructions. Twenty-four hours later, cells were fixed with 2% paraformaldehyde
during 15 min. Immunofluorescence was performed as described below with a mouse monoclonal
anti-GFP antibody (Thermo Fisher Scientific, Waltham, MA, USA) at a 1/500 dilution and DAPI
dilactate (4’,6-Diamidino-2-Phenylindole Dihydrochloride, Molecular Probes, Thermo Fisher Scientific,
Waltham, MA, USA) at 1/30000 dilution. Cells were observed under a confocal microscope (Zeiss LSM
710 or 780 Quasar Confocal Microscope, Feldbach, Switzerland) at the Cellular Imaging Facility of
Lausanne University.
2.7. Purification of Wcw_1706 for Pull Down Experiments and Antibodies Production
The wcw_1706 full gene was cloned in pCWR547 using NdeI and SacI restriction sites. This
plasmid allows addition, at the N-terminal end of the protein of interest, of a 6His tag, followed
by a SUMO protease recognition site [34]. Recombinant protein was expressed in BL21 E. coli and
purified on a Ni-NTA agarose (Quiagen, Hombrechtikon, Switzerland) column under native conditions
following the manufacturer’s protocol. After purification, the 6His tag was removed by digestion with
SUMO protease (Invitrogen, Thermo Fisher Scientific, Waltham, MA, USA) and the untagged protein
was separated from cleaved 6His tag and non-digested 6His_SUMO_Wcw_1706 using Ni-NTA agarose.
The non-tagged Wcw_1706 protein was used in pull down experiments and to elicit polyclonal mouse
antibodies (Eurogentec, Liège, Belgium).
2.8. Pull Down Experiments
W. chondrophila T3SS chaperones Wcw_0969, Wcw_0616 and Wcw_0348 were identified by their
sequence homology with chlamydial chaperones using ChlamDB [35]. W. chondrophila chaperone
genes were cloned in pET15b and 6 His-tagged proteins were expressed in E. coli BL21 upon addition
of 1 mM IPTG to the culture medium. Pull down experiments were performed using the Pierce Pull
down PolyHis Protein:Protein Interaction kit (Thermo Fisher Scientific, Waltham, MA, USA) following
manufacturer’s instructions. Briefly, His-tagged chaperones recovered from 5 mL E. coli cultures were
fixed on HisPur Cobalt resin by a 1.5 h incubation at 4 ◦C in Tris buffer containing 10 mM imidazole.
Cultures of non-transformed E. coli were used as negative control. After 5 washes in presence of 20 mM
imidazole, Cobalt column were incubated during 2 h at 4 ◦C with purified non-tagged Wcw_1706
protein in phosphate buffer containing 40 mM imidazole and 500 mM NaCl. Columns were washed
5 times with wash buffer containing 20 mM imidazole and protein complexes were eluted 2x from the
Cobalt resin using 290 mM imidazole.
Alternatively, a GST-tagged version of Wcw_1706 was produced in E. coli BL21 upon addition of 1
mM IPTG to the culture medium. GST pull down experiments were performed with GST-tagged_Wcw
_1706 and His_tagged chaperones Wcw_0969, Wcw_0616 and Wcw_0348 using the Pierce™ GST
Protein Interaction Pull-Down Kit (Thermo Fisher Scientific, Waltham, MA, USA), following the
manufacturer’s instructions.
All fractions were analysed by SDS-PAGE and immunoblotting.
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2.9. Immunoblots
2.9.1. Y. enterocolitica Secretion Assays
TCA-precipitated supernatant fractions and pellets were analysed by SDS-PAGE and
immunoblotting as described in Kebbi-Beghdadi et al. [36]. Proteins of interest were detected using
a mouse monoclonal anti-V5 epitope antibody (Invitrogen, Thermo Fisher Scientific, Waltham, MA,
USA) (1/5000 dilution) or anti β lactamase antibody (VWR International GmbH, Dietikon, Switzerland)
(1/1000 dilution) and MreB was detected using a home-made rabbit polyclonal antibody (1/5000
dilution). First antibodies were incubated overnight at 4 ◦C. Secondary antibodies, goat anti-mouse
IgG-HRP (BioRad, Cressier, Switzerland) and donkey anti-rabbit IgG-HRP (Promega, Dübendorf,
Switzerland), both diluted 1/3000 were applied during 1 h at room temperature. Immunoblots
were revealed with ECLTM Prime Western Blotting Detection Reagent (Amersham, GE Healthcare,
Glattbrugg, Switzerland) and analysed on ImageQuant LAS4000 mini (Amersham, GE Healthcare,
Glattbrugg, Switzerland).
2.9.2. W. chondrophila Infected Cells
W. chondrophila-infected Vero cells and culture supernatants were harvested at different time
points after infection and DNA was extracted from a 50 µL aliquot using Wizard SV genomic DNA
extraction kit (Promega, Dübendorf, Switzerland). Bacteria were quantified using a W. chondrophila
specific qPCR [9] as described in Kebbi-Beghdadi et al. [25]. Cells and bacteria from one T25 flask were
pelleted by 5 min centrifugation at 12,000g. Pellets were washed with PBS and resuspended in 500 µL
of SDS-PAGE loading buffer. Proteins were analysed by SDS-PAGE and immunoblotting as described
in Kebbi-Beghdadi et al. [36]. Wcw_1706 was detected with a polyclonal mouse anti-Wcw_1706
antibody diluted 1/1000 in TBS with 0.05% Tween 20 and 5% non-fat dry milk and incubated overnight
at 4 ◦C. Goat anti-mouse IgG-HRP conjugated antibodies (BioRad, Cressier, Switzerland (1/3000
dilution) were applied during 1 h at room temperature. Immunoblots were revealed with ECLTM Prime
Western Blotting Detection Reagent (Amersham, GE Healthcare, Glattbrugg, Switzerland) and images
acquired on ImageQuant LAS4000 mini (Amersham, GE Healthcare, Glattbrugg, Switzerland). Signal
intensities were measured with ImageJ, normalised according to the number of bacteria determined by
quantitative PCR and expressed as a percentage of the maximum value.
2.9.3. Pull Down Experiments
All fractions were analysed by SDS-PAGE and immunoblotting as described in Kebbi-Beghdadi et al. [36].
The mouse polyclonal anti_Wcw_1706 antibody diluted 1/1000 was incubated overnight at 4 ◦C in TBS
with 0.05% Tween 20 and 5% non-fat dry milk. Mouse monoclonal anti-GST (Sigma-Aldrich, Buchs,
Switzerland) and anti-His (Sigma-Aldrich, Buchs, Switzerland) antibodies were diluted respectively
1/1000 or 1/3000 and incubated during 2 h at room temperature in TBS with 0.05% Tween 20 and
0.5% non-fat dry milk. Secondary goat anti-mouse IgG-HRP (BioRad, Cressier, Switzerland) antibody
(1/3000 dilution) was applied during 1 h at room temperature. Immunoblots were revealed with
ECLTM Western Blotting Detection Reagent (Amersham, GE Healthcare, Glattbrugg, Switzerland) and
analysed on ImageQuant LAS4000 mini (Amersham, GE Healthcare, Glattbrugg, Switzerland).
2.10. Gene Expression
W. chondrophila-infected Vero cells and culture supernatants were collected in TRIzol (AmbionR,
Life Technologies, Thermo Fisher Scientific, Waltham, MA, USA) at different time points after infection.
RNA was extracted as described in Chomczynski and Mackey [37]. Random primers and the GoScript
Reverse Transcription kit (Promega, Dübendorf, Switzerland) were used to produce cDNA that was
analysed by quantitative PCR using I Taq SYBRGreen technology (BioRad, Cressier, Switzerland).
qPCR were performed with 4 µL of cDNA diluted 1/5 and 300 nM (16S and wcw_0499) or 200 nM
(wcw_1706) of the following primers:
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16S for: 5′ GGCCCTTGGGTCGTAAAGTTCT 3′
16S rev: 5′ CGGAGTTAGCCGGTGCTTCT 3′
wcw_1706 for: 5’ TTGACGCTTGTCGAGGTTCA 3’
wcw_1706 rev: 5’ GCAAAAACTCCGGCACTTCC 3’
wcw_0499 for: 5’ TGTGCGTGAGTTTTCAGAGGA 3’
wcw_0499 rev: 5’ TTTATTGGTTTGCAGGGCGC 3’
Cycling conditions were 10 min at 95 ◦C, followed by 40 cycles of 15 s at 95 ◦C and 1 min at
60 ◦C. PCR products were amplified and detected with the StepOne Real-Time PCR System (Applied
Biosystems, Zug, Switzerland). qRT-PCR results were analysed using 16S rRNA gene as an endogenous
control and 48 h pi as the reference time point.
2.11. Immunofluorescence and Confocal Microscopy
Vero cells were grown during 16 h on glass coverslips and infected with W. chondrophila as
described above. At 8, 16, 24 and 32 h post infection, cells were fixed with ice-cold methanol during
5 min at –20 ◦C, washed three times with PBS and incubated at least 2 h in blocking solution (PBS, 0.01%
NaN3, 1% BSA) at 4 ◦C. Coverslips were incubated with a mouse anti-Wcw_1706 antibody diluted
1/1000 in PBS, 0.1% saponin, 1% BSA or with a mouse antibody elicited against a Wcw_0499 peptide
(aa 128 to 141) diluted 1/500 in the same solution. First antibodies were applied during 2 h at room
temperature. After three washing steps in PBS, 0.1% saponin, coverslips were incubated with a 1/500
dilution of AlexaFluor 488-conjugated goat anti-mouse antibody (Life Technologies, Thermo Fisher
Scientific, Waltham, MA, USA) and a 1/30000 dilution of DAPI dilactate (4’,6-Diamidino-2-Phenylindole
Dihydrochloride, Molecular Probes, Thermo Fisher Scientific, Waltham, MA, USA). Secondary antibody
was applied during 1 h at room temperature. After 2 washes with PBS 0.1% saponin, 1 with PBS and 1
with deionised water, the coverslips were mounted onto glass slides using Mowiol (Sigma-Aldrich,
Buchs, Switzerland). Cells were observed under a confocal microscope (Zeiss LSM 710 or 780 Quasar
Confocal Microscope, Feldbach, Switzerland) at the Cellular Imaging Facility of Lausanne University.
3. Results
3.1. Selective Eukaryotic Membrane Permeabilisation Identifies Secreted Bacterial Proteins
Intracellular bacteria secrete effectors in the host cell cytosol to modulate their environment and
create favourable conditions to complete their life cycle. To identify bacterial proteins present in host
cell cytosol, we used perfringolysin O (PFO), an exotoxin produced by Clostridium perfringens that
forms pores in cholesterol-containing membranes.
Perfringolysin O was previously demonstrated to allow transient permeabilisation of the eukaryotic
plasma membrane without disruption of the inclusion membrane integrity [31]. We analysed by mass
spectrometry the culture medium of perfringolysin O-treated HEp2 cells infected with C. trachomatis or
W. chondrophila. This fraction contains the cytosolic proteins, including host cell proteins, as well as
proteins secreted by bacteria. Infected but non-permeabilised cells were used as control to take account
of bacteria still present in the culture medium after the infection procedure and of putative host cell
lysis. All bacterial proteins identified in the PFO-treated sample and absent in mock-treated control
as well as those enriched more than 1.5 times in the PFO-treated sample versus the mock control are
presented in Supplementary Table S1. This list includes several proteins, such as chaperones (DnaK,
GroL, GroS), ribosomal proteins (50S ribosomal proteins L7/L12, L9 and L10, 30S ribosomal protein
S6) or elongation and initiation factors (Elongation factors Tu, Ts and G, Translation initiation factor
IF-1) that are repeatedly retrieved in mass spectrometry analyses performed on different fractions
containing W. chondrophila proteins [36,38,39]. They are probably very abundant proteins and likely
represent technical contaminants. For the sake of simplification, they were discarded from the results
of Table 1 that presents proteins presumably secreted by C. trachomatis or by W. chondrophila in the
cytosol of their host cell.
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Interestingly, the Chlamydial Protease-like Activity Factor (CPAF) was retrieved in the cytosol
of cells infected with C. trachomatis (CT858) or with W. chondrophila (Wcw_0991). This protein is an
important virulence factor detected in the host cell cytoplasm in several studies [40–43]. Furthermore,
in the analyses of cells infected with C. trachomatis, we retrieved with high confidence the Chlamydia
protein Associating with Death Domains (CADD) (CT610), a protein secreted by the Type III Secretion
System (T3SS) and capable of interacting with mammalian death receptors [44,45]. The recovery of these
known secreted proteins in our analyses validates the use of the PFO permeabilisation method to identify
new bacterial effector proteins secreted in host cell cytosol. Although in the case of intracellular bacteria
Sec-dependent secretion systems usually deliver proteins in the lumen of the bacteria-containing
vacuole (i.e., in the lumen of the inclusion for Chlamydiales bacteria), effectors can also travel from the
inclusion lumen to the host cell cytosol through outer membrane vesicles [19,46]. Interestingly 3 out of
13 (23%) proteins identified in the cytosol of cells infected with C. trachomatis display a predicted signal
peptide, while it is the case for 13 out of 19 (68%) in W. chondrophila-infected cells.
Table 1. Proteins presumably secreted by C. trachomatis or by W. chondrophila in their host cell cytosol.




Name Weight Peptide Prediction 1 as
C. trachomatis
CT_610 PqqC-like protein (CADD) 27 kDa NO 0 secreted [45]
CT_460 SWIB (YM74) complex protein 10 kDa NO 1 nd
CT_112 Oligoendopeptidase pepF 69 kDa NO 1 nd
CT_539 Thioredoxin trxA 11 kDa NO 1 not secreted [47]
CT_771 Hydrolase/phosphatase homolog 17 kDa NO 0 nd
CT_242 Skp-like protein 19 kDa YES 1 nd
CT_707 Trigger factor tig 50 kDa NO 2 nd
CT_432 Serine hydroxymethyltransferase glyA 54 kDa NO 1 nd
CT_691 Hypothetical protein 25 kDa YES 1 nd
CT_505 Glyceraldehyde-3-phosphate
dehydrogenase
gapA 36 kDa NO 0 nd
CT_603 Thio-specific Antioxidant (TSA)
Peroxidase
ahpC 22 kDa NO 0 nd
CT_858 Chlamydial protease-like activity
factor
cpaf 67 kDa YES 0 secreted [42,48]
CT_507 DNA-directed RNA polymerase
subunit alpha
rpoA 42 kDa NO 0 nd
W. chondrophila
wcw_0501 Hypothetical protein 47 kDa YES 3 nd
wcw_0432 DO serine protease htrA3 52 kDa YES 0 nd
wcw_0499 Hypothetical protein 18 kDa NO 1 secreted
(this study)
wcw_1545 Nucleoside diphosphate kinase ndk2 18 kDa YES 0 nd
wcw_0991 Putative chlamydial protease-like
activity factor
cpaf 67 kDa YES 0 nd
wcw_1192 Putative Skp-like protein ompH 21 kDa YES 1 nd
wcw_1543 Nucleoside diphosphate kinase ndk1 16 kDa NO 0 nd
wcw_0657 Hypothetical protein 26 kDa YES 0 nd
wcw_0453 Putative rhs family protein rhs11 200 kDa YES 0 nd
wcw_0967 Hypothetical protein 31 kDa YES 0 nd
wcw_0878 NADPH-dependent FMN reductase 23 kDa YES 0 nd
wcw_1529 Peptidyl-prolyl cis-trans isomerase mip3 28 kDa YES 0 nd
wcw_0704 Hypotheticalprotein 526 kDa NO 1 nd
wcw_1706 Hypothetical protein 28 kDa NO 1 secreted
(this study)
wcw_0680 Hypothetical protein 40 kDa YES 0 nd
wcw_0715 RNA-binding protein rbp 10 kDa NO 0 nd
wcw_0969 Hypothetical protein 18 kDa NO 0 nd
wcw_1068 Peptidyl-prolyl cis-trans isomerase ppiB 22 kDa YES 0 nd
wcw_1301 Hypothetical protein 17 kDa YES 1 nd
Bacterial proteins identified by mass spectrometry analysis in the culture medium of perfringolysin O-treated HEp2
cells infected with C. trachomatis or W. chondrophila. nd: not determined 1 Number of algorithms predicting secretion
by T3SS (out of 4) [35].
Chlamydiales bacteria also possess a T3SS able to secrete virulence factors directly into the host
cell cytosol. Seven out of ten proteins without a predicted N-terminal signal peptide identified in the
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experiment with C. trachomatis and 3 out of 6 identified in the experiment with W. chondrophila are
predicted to be T3SS effectors by at least one algorithm trained in silico to recognise such secreted
proteins [35].
Altogether, a large majority of the proteins identified with the PFO permeabilisation protocol are
predicted to be secreted proteins, which confirms the relevance of this technique for the identification
of new bacterial effector proteins.
3.2. Four Newly Identified Putative Chlamydial Effector Proteins Are Secreted by Yersinia enterocolitica T3SS
Members of the Chlamydiales order have been historically recalcitrant to genetic modifications.
During the last decade, a few systems were developed to manipulate genetically C. trachomatis but
Chlamydia-related bacteria remain intractable for now [49]. Heterologous systems are thus mandatory
to study chlamydial genes and pathways and in particular the T3SS. In this study, we used Yersinia
enterocolitica to assess T3SS-dependent secretion of four putative secreted proteins identified by PFO
permeabilisation: CT460, CT432, Wcw_0499 and Wcw_1706. These proteins are predicted in silico to be
T3SS effectors by one algorithm trained to identify such secreted proteins (T3_MM model [50] for CT432,
CT460, Wcw_1706 and effective T3 [51] for Wcw_0499) and they do not possess a predicted N-terminal
signal peptide [35]. The four proteins tagged with a V5 epitope were expressed in Y. enterocolitica
T3SS-proficient (HOPEMT) and T3SS-deficient (HOPEMT YscU) strains under the control of the Yersinia
yopE gene promoter [32]. We analysed by immunoblot the presence of the tagged proteins in the
bacterial pellets and in the culture supernatants from both strains. As depicted on Figure 1a, efficient
expression of the four proteins in both T3SS-proficient and T3SS-deficient strains was validated by their
detection in the bacterial pellets. In addition, all four proteins were present in the culture medium of the
T3SS-proficient strain and absent in the supernatant of the T3SS-deficient one (Figure 1b). Interestingly,
the secreted form of Wcw_0499 was slightly smaller than the form detected in the pellet fraction. This
size shift was observed consistently in every experiment performed with this protein and probably
indicates a proteolytic cleavage that could be associated with an activation of the secreted form.
Three proteins were used as controls in this assay (Figure 1c): (i) a truncated form of the E. coli β
lactamase lacking its signal peptide (TEM without SP) that should not be secreted, (ii) CPAF, a protein
secreted by a Sec-dependent pathway [46] and (iii) the C. trachomatis translocated early phosphoprotein,
TepP (CT875), a known T3SS effector [52,53]. These three control proteins were detected in the bacterial
pellets of both Y. enterocolitica strains, demonstrating efficient expression. TEM without SP was not
present in the culture supernatant of either strain, whereas CPAF was detected in both HOPEMT and
HOPEMT YscU supernatants. TepP was detected only in the case of a functional T3SS. To exclude
bacterial lysis or fraction contamination, the supernatant fractions were probed against the strictly
cytosolic Y. enterocolitica MreB protein (Supplementary Figures S1–S3) [33].
In addition, T3SS-dependent secretion of Wcw_1706 was also convincingly demonstrated using
a third Y. enterocolitica strain in which secretion depends on the presence of calcium in the culture
medium (Supplementary Figure S4 [33,54]).
Altogether, our results demonstrated that the four putative secreted effector proteins that we
selected for analysis in the Y. enterocolitica system are indeed secreted by a heterologous T3SS, thus
validating at once the relevance of the PFO permeabilisation technique to uncover new T3SS effectors
and the significance of algorithms to predict such effectors.
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Figure 1. T3SS-dependent secretion in Y. enterocolitica. The putative secreted proteins Wcw_0499,
Wcw_1706, CT432 and CT460 tagged with a V5 epitope were detected by immunoblot in the bacterial
pellet (a) or in the culture supernatant (b) of Y. enterocolitica T3SS-proficient (∆HOPEMT) and
T3SS-deficient (∆HOPEMT ∆YscU) strains. (c) Control experiments were performed with TEM
without signal peptide (no secretion), CPAF (secreted by T2SS [43]) and TepP (secreted by T3SS [50,51]).
For each protein, result of one representative experiment is presented in the figure but all experiments
were repeated 3 times independently with congruent results. Blots were cropped and grouped, see
Supplementary Figures S1–S3 for complete blot pictures.
3.3. CT460 Localises in Host Cell Nucleus upon Transfection
The putative T3SS effector CT460 contains a SWIB/MDM2 domain potentially involved in
chromatin remodelling. Furthermore, the W. chondrophila homolog of this protein, Wcw_0377, was
recently demonstrated to be associated with bacterial DNA in infected Vero cells and to localise in
the host nucleus in transfected 293T cells [55]. We wondered if a similar nuclear localisation could
be observed with CT460. To answer this question, we transfected 293T cells with a GFP-tagged
version of CT460 and CT432, a serine hydroxymethyltransferase that is presumably not associated
with nuclei, and we analysed their localisation by immunofluorescence. A W. chondrophila cytosolic
protein, Elongation factor Tu (EfTu) fused to GFP and GFP alone were used as negative controls in these
experiments. As shown in Figure 2, the green signal corresponding to CT460-GFP clearly co-localised
with the DAPI staining of nucleus in transfected cells, while CT432-GFP and the two negative control
proteins were mainly localised in 293T cell cytoplasm. Similar results were obtained with the GFP
tag located at the C-terminus or at the N-terminus of CT460. These results suggest that, similarly to
the T3SS effector NUE [56], CT460 could localise in the nucleus of infected cells and play a role in
chromatin remodelling. Interestingly, we could also demonstrate that the W. chondrophila homolog of
CT460, Wcw_0377, is secreted by the Y. enterocolitica T3SS (data not shown), which further supports the
putative secretion of these two proteins through chlamydial T3SS during infection and emphasises the
efficiency of the PFO method to discover new potential effectors.
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3.4. Wcw_0499 Is an Early to Mid-Cycle Effector Protein
W. chondrophila has a much broader host range than C. trachomatis and probably encodes a
larger numbe of effectors specific lly associ ted with this distinctive characteristic. Thus, this
Chlamydia-r lated bacterium repre ents an in eresting model to study how Chlamydiales b cter
manipulate heir host cell a d which stra egies they have evolved to survive in divers enviro ments.
In this re pect, we furt er char cteri ed two W. chondrophila proteins of unknown function, Wcw_0499,
that is strictly specific to W. chon rophila, and Wcw_1706, a protein with homologs i all other species
of the Chlamydiales rder [35].
Previously published studies by our group showed that in Vero cells EBs differentiate into RBs
as early as 3 h post infection (p ). Exp nential multiplication takes place between 8 and 32 h, then
RBs as nchronously r -differentiate i to EBs that are released by host cell lysis. In this cell line,
W. chondrophila completes its replica ion cycle in bout 48 h [25,36].
To assess the transcriptional profile of wcw_0499 gene during a complete W. chondrophila replication
cycle, we extracted RNA from W. chondrophila-infected Vero cells at different tim points during t e
course of infection. We performed RT-qPCR usi g the 16SrRNA gene as an internal reference a d
normalised the results to wcw_0499 gene expr ssion at 48 h pi. Da a presented in Figure 3a indicate
that the wcw_0499 gene is transcribed very early during the d velopmental cycle of th bact ria, with a
peak of transcrip ion detected at 3 h pi.
We then analysed by immunofluoresc nce the expression and localisation of Wcw_0499 during the
course of a W. chondrophila infection in Vero cells. The signal c rresponding to Wcw_0499 co-localised
with the DAPI staining of growing bacteria (RBs) but could be dete ted only from 16 h pi onwards
(Figure 3b), w ic suggest that Wcw_0499 is we kly expressed. As can be se n in Figure 3b, the signal
c rresponding to Wcw_0499 precisely co-localised with DAPI staining of bacterial DNA at 16 and
24 h pi. At 32 h pi, the Wcw_0499 specific signal was less strongly s aining bacter a and could so be
detected outside the inclusion, in host cell cytoplasm, sug esting a possible secretion (Fi ure 3b, white
arrows). This observation is consiste t with previou results (Table 1), howing th t Wcw_0499 could
be ret ieved in he h st cell cyt plasm but should b taken cautiously since secretion i difficul to
observe at such late time points when larg inclusions occupy most of th eukaryotic cell ytoplasm.
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Nevertheless, our results indicate that Wcw_0499 is an early to mid-cycle effector protein, detected in
the host cell cytosol at late stages of infection.
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Wcw_0348, a protein with a tetratricopeptide repeat-containing domain, is homologous to class II 
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Figure 3. Wcw_0499 is an early to mid-cycle effector detected in the host cell cytosol at late stages of
infection (a) Wcw_0499 transcriptional expression was analysed by RT-qPCR during the course of an
infection in Vero cells and normalised at 48h pi according to 16SrRNA gene expression. Results are
the mean and SD of three independent experiments. At 3 h post infection, expression could only be
detected in one experiment. nd: not detected. (b) Vero cells infected with W. chondrophila were stained
with a polyclonal mouse antibody against Wcw_0499 (green) and DAPI (blue) at 16, 24 and 32 h post
infection. White arrows point at area where secretion can be observed. Scale bar: 20µm.
3.5. Wcw_1706 Is a Mid-Cycle Effector Protein Interacting with a T3SS Class II Chaperone
We then focused our interest on Wcw_1706, a protein of unknown function encoded in the genome
of all bacteria of the Chlamydiales order. The transcriptional pattern of wcw_1706 ge e was termined
by RT-qPCR at different time points following infectio of Ver cells with W. chondrophila and the
profile presented in Figure 4a indicates that wcw_1706 is transcribed early during t e development l
cycle, with a peak of transcription d tected at 8 h pi.
Prot i expression was analysed i infected cells by immunoblot using a specific anti-Wcw_1706
antibody. Relative abund nce of the protein was quantified by rmalising the signal measured on the
blot according to the number f bacteria loaded in e ch lane as assessed by quantitative PCR [9]. The
ighest pr tein expression (d fined s 100%) was observed at 16 h pi but the low sensitivity of this
technique did not allow detection before this time point (Figure 4b). Protein expression could also be
visualised by immunofluorescence staining of infected Vero cells. This technique allowed detection
of a signal corresponding to Wcw_1706 alre dy at 8 h pi (Figure 4c). At this and later time points,
the specific signal corresponding to Wcw_1706 nicely co-localised with the DAPI staini g of bacterial
DNA in inclusions.
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down experiment with Wcw_1706 and the three T3SS chaperones Wcw_0969, Wcw_0616 and 
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4. Discussion 
In this study, we used the pore-forming toxin perfringolysin O to selectively permeabilise the 
plasma membrane of eukaryotic infected cells without disrupting the inclusion membrane. This 
protocol, described by Kleba and Stephens in 2008, allowed a mass spectrometry analysis of the 
culture medium containing all cytosolic proteins, including secreted bacterial effectors, but with a 
limitation to soluble and relatively small proteins. Effectors that would bind to membrane proteins 
or interact in complexes with host cell components for example could remain trapped within the cell 
during PFO treatment. Twenty-one C. trachomatis and 28 W. chondrophila proteins were identified in 
this analysis. Among them are abundant proteins such as chaperones, ribosomal proteins or 
elongation and initiation factors that are repeatedly retrieved in W. chondrophila mass spectrometry 
Figure 4. Wcw_1706 is a mid-cycle effector protein interacting with a T3SS class II chaperone (a)
wcw_1706 transcriptional profile was analysed by RT-qPCR during the course of an infection in Vero cells
and normalised at 48h pi according to 16SrRNA gene expression. Results are the mean and SD of three
independent experiments. nd: not detected. (b) Wcw_1706 expression was monitored by immunoblot
during the course of an infection in Vero cells. Arrow indicates the band corresponding to Wcw_1706.
Full-length immunoblot is presented in Supplementary Figure S5. The signal intensity measured with
ImageJ was normalised according to the number of bacteria in the sample and expressed as percentage
of the maximum value. Results are the mean and SD of three independent experiments. nd: not
detected. (c) Vero cells infected with W. chondrophila were stained with a polyclonal antibody against
Wcw_1706 (green) at 8, 16, 24 and 32 h post infection. DNA is stained with DAPI (blue). Scale bar: 20 µm.
(d) Immunoblot analysis of elution fractions 1 and 2 from a pull down experiment with Wcw_1706
and the three T3SS chaperones Wcw_0969, Wcw_0616 and Wcw_0348. Negative control = no protein.
A mouse polyclonal anti-Wcw_1706 antibody was used to probe the blot. Full-length immunoblot is
presented in Supplementary Figure S6. Experiments were repeated three times independently with
congruent results.
Most T3SS effectors require specific bacterial chaperones for proper folding and delivery into host
cell cytosol. We assessed by pull down experiments the binding of Wcw_1706 to three W. chondrophila
T3SS chaperones that were identified by sequence homology to known chlamydial chaperones.
Wcw_0969 is homologous to SlcI (61% sequence identity), Wcw_0616 is the W. chondrophila counterpart
of Multiple Cargo Secretion Chaperone (Mcsc) (29% sequence identity) and Wcw_0348, a protein
with a tetratricopeptide repeat-containing domain, is homologous to class II chaperone CT274 (51%
sequence identity) [21,57,58]. Elution fractions of a pull down experiment with Wcw_1706 and the three
above-mentioned W. chondrophila chaperones were analysed by immunoblot using anti-Wcw_1706
antibody. As show in Figure 4d, no specific interaction could be detected between Wcw_1706 and
chaperones Wcw_0969 and Wcw_0616. Wcw_1706 was recovered only in pull down experiments
with chaperone Wcw_0348 indicating a clear interaction between this T3SS effector and the class II
chaperone. This result was further confirmed using a GST-tagged version of 1706 (Supplementary
Figure S7). The interaction of Wcw_1706 with a T3SS chaperone further supports the results obtained
in the Y. enterocolitica secretion assay, suggesting that this protein is a T3SS effector.
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4. Discussion
In this study, we used the pore-forming toxin perfringolysin O to selectively permeabilise the
plasma membrane of eukaryotic infected cells without disrupting the inclusion membrane. This
protocol, described by Kleba and Stephens in 2008, allowed a mass spectrometry analysis of the culture
medium containing all cytosolic proteins, including secreted bacterial effectors, but with a limitation
to soluble and relatively small proteins. Effectors that would bind to membrane proteins or interact
in complexes with host cell components for example could remain trapped within the cell during
PFO treatment. Twenty-one C. trachomatis and 28 W. chondrophila proteins were identified in this
analysis. Among them are abundant proteins such as chaperones, ribosomal proteins or elongation and
initiation factors that are repeatedly retrieved in W. chondrophila mass spectrometry analyses [36,38,39]
and thus likely represent contaminant abundant proteins. The remaining 13 C. trachomatis and 19
W. chondrophila putative secreted proteins include the Chlamydial Protease-like Activity Factor (CPAF),
that was retrieved in screenings with both bacteria, and the Chlamydiaceae specific CADD (Chlamydia
protein Associating with Death Domains). Secretion was previously demonstrated for these two
proteins [42,45]. CPAF is a protease exhibiting a predicted N-terminal signal peptide. It is first secreted
in the inclusion lumen by the T2SS, and later reaches the host cell cytosol by a yet unclear mechanism.
It modulates several host cell pathways to evade the innate immune response and promote bacterial
survival (reviewed in [20]). CADD is secreted by the T3SS into the host cytoplasm, where it co-localises
with tumour necrosis factor receptors and interacts with their death domains to modulate apoptosis
pathways [45]. On the opposite, CT539, a thioredoxin involved in the reduction of oxidized cysteine
residues and the cleavage of disulphide bonds, was reported by Wu et al. not to be secreted in the
host cell cytoplasm using conventional fluorescence microscopy [45]. The discrepancy between these
results and our data could be due to different sensitivities of the technique used, MS analyses being far
more sensitive than immunofluorescence. On this point, it is worth noting that in a list of 30 effector
proteins of C. trachomatis published by Bugalhao and Mota [20], only one third were observed in the
host cell cytoplasm using immunofluorescence [46,48,59–65]. Alternatively, CT539 could also be a very
abundant but not secreted protein contaminating our results as described above for ribosomal proteins.
Remarkably, 8 out of 13 C. trachomatis putative effectors identified with the PFO permeabilisation
protocol and 16 out of 19 W. chondrophila putative effectors are predicted in silico to be T3SS effectors or
contain a N-terminal signal peptide for the general secretory pathway, or both. Our experiments using
the heterologous system Y. enterocolitica to assess T3SS-dependent secretion of four proteins predicted
in silico to be T3SS substrates demonstrated that algorithms are indeed able to predict secretion by
the T3SS. Thus, it is reasonable to hypothesise that proteins in Table 1 predicted to be T3SS effectors
based on computer analyses are likely to be secreted in the host cell cytosol. On the other hand,
the Sec system translocates into the periplasmic space proteins that can further be exported in the
inclusion lumen via the T2SS or outer membrane vesicles (OMVs). These vesicles will ultimately fuse
with or pass through the inclusion membrane liberating the proteins in the host cell cytosol [20,46].
Indeed, CPAF (that possesses a signal peptide) was detected experimentally in host cytosol in several
independent studies [40–43]. We can reasonably assume that other proteins exhibiting a predicted
signal peptide might also be secreted within the host cell cytosol. OMVs consist of periplasmic content,
membrane-bound proteins, lipopolysaccharides and phospholipids [66]. The identification in the
cytosol of cells infected with C. trachomatis or with W. chondrophila of a Skp-like protein that can interact
with membrane lipids and lipopolysaccharides is in line with this explanation [67].
The eight proteins found secreted in the present study, which do not harbor a N-terminal signal
peptide and are not predicted in silico to be T3SS effectors could have reached the host cytoplasm in
association with other proteins or by yet unknown mechanisms.
In agreement with their detection in the host cell cytoplasm, 5 out of 13 C. trachomatis putative
secreted proteins (CT610, CT112, CT242, CT603 and CT507) were previously demonstrated to be
immunogenic proteins [47,68–70]. After host cell lysis, these proteins are probably released in the
extracellular space where they can be recognized by the immune system.
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As inferred from their putative function, several of the newly identified putative secreted
effectors could interfere with cellular metabolic pathways and host defence mechanisms to bacterial
benefit. CT460 is of particular interest given its putative chromatin remodelling SWIB/MDM2 domain.
Wcw_0377, the W. chondrophila homolog of CT460 possesses the same SWIB/MDM2 domain and
was recently demonstrated to reach the host cell nucleus where it could interact with eukaryotic
histones [53]. The SWIB/MDM2 domain is mainly present in eukaryotic proteins and rarely found in
bacterial proteins [35], suggesting that proteins containing such domains are likely to be implicated
in bacteria-host interactions. Our results using the Y. enterocolitica secretion assay demonstrated
that CT460 as well as Wcw_0377 are T3SS substrates. In addition, ectopic transfection in 293T cells
indicated a nuclear localisation of these two proteins (this study and [53]). These findings suggest that
CT460/Wcw_0377 could be nuclear effectors possibly exhibiting a methyltransferase activity towards
eukaryotic histones similarly to NUE, a T3SS effector that localises in the nucleus of infected cells and
is thought to methylate histones and remodel chromatin [54].
C. trachomatis and W. chondrophila belong to the same phylogenetic order and share several
important features of strict intracellular bacteria. In this respect, it is worth noting that two proteins,
CPAF (CT858 and Wcw_0991) and the Skp-like protein OmpH (CT242 and Wcw_1192), were identified
both in the experiments with C. trachomatis and with W. chondrophila. This interesting result suggests
that some eukaryotic pathways important for bacterial survival and replication are targeted similarly by
all member of the Chlamydiales order. On another hand, C. trachomatis and W. chondrophila display large
differences in their host range and intracellular trafficking that are very likely partly due to a distinct
arsenal of T3SS effectors. W. chondrophila also possesses a much larger genome than C. trachomatis and
consequently encodes potentially many more effectors [71]. Thus, studying W. chondrophila specific
effectors could provide great opportunities to understand the strategies evolved by the different
members of the Chlamydiales order to survive in their diverse host environments. Indeed, among the
bacterial proteins identified in the cytosol of W. chondrophila-infected Vero cells, three hypothetical
proteins Wcw_0499, Wcw_0680 and Wcw_0704 are only present in W. chondrophila and are thus of
particular interest.
The transcription profile of wcw_0499 revealed that this gene is transcribed at the very beginning
of the developmental cycle suggesting that the corresponding protein could interfere with early
mechanisms of host cell response to infection. This protein could be linked to the ability of W. chondrophila
to survive in different cells including amoebae and macrophages, an ability probably related to the
rapid escape of the bacterium from the endocytic pathway [16]. Alternatively, Wcw_0499 could be
also implicated in the recruitment of mitochondria around the W. chondrophila inclusion, an event
that occurs very rapidly after bacterial entry in the host [16]. Determining the host cell component(s)
interacting with Wcw_0499 will help resolving this question und unravel part of the chlamydial
evolution and virulence.
Our immunofluorescence experiments suggested secretion of Wcw_0499 in Vero cell cytosol at
32 h pi. No secretion could be observed at earlier time points even though this protein was identified
in the cytosol of infected HEp2 cells 24 h pi. This difference could be due to a different timing of
W. chondrophila replication cycle in these two cell lines. It could also reflect a technical limitation in the
detection by immunofluorescence of small amount of protein secreted in the host cell cytosol. Indeed,
as mentioned above, chlamydial secreted effector proteins are notably difficult to observe by confocal
microscopy in the cytosol of infected cells, certainly due to their low amount and to their transient time
of secretion. Wcw_1706 is a hypothetical protein of unknown function identified as immunogenic in a
previous work by Lienard et al. [39]. It is a Chlamydiales-specific protein, conserved throughout the
phylum and presenting about 50% sequence homology with its chlamydial homologs such as CT538
and Cpn_0658 [72]. We demonstrated in the present study that a full-length version of Wcw_1706 is
secreted by the T3SS of Y. enterocolitica. However, two previously published studies indicated that
CT538 and Cpn_0658 are not T3SS substrates [32,73]. These results were obtained in secretion assays
performed with the N-terminal part of the protein (about 40 aa) fused to a reporter gene in Yersinia or
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Shigella heterologous systems. Since CT538 and Cpn_0658, that have 77% amino acids identity in their
N-terminal region, share only 40% identity with Wcw_1706 in this same region, it is not surprising that
Wcw_1706 behaves differently in the Yersinia secretion assay.
Nothing is known about the function of Wcw_1706 or its chlamydial homologs and no clue
can be inferred from their amino acid sequences. However, our results demonstrated that wcw_1706
transcription is maximal at 8 h pi, when exponential bacterial multiplication starts within an
inclusion that is already tightly associated with mitochondria and localised in the endoplasmic
reticulum [16]. This expression profile suggests a role for Wcw_1706 in nutrient acquisition or
disruption of cellular pathways.
Finally, CT538, the C. trachomatis homolog of Wcw_1706, is one of the 10 iron-responsive proteins
identified by Dill et al. [74]. Surprisingly, four other proteins, whose expression was increased when
bacteria were grown in iron-restricted versus iron-sufficient conditions (CT507, CT603, CT610 and
CT707), were identified in the host cell cytosol in our PFO assay. In addition, transcriptional studies
revealed an upregulation of CT112, CT432 and CT505 when infected cells were grown respectively in
presence of an iron chelator or of IFN gamma [75,76]. Altogether 7 out of 13 C. trachomatis proteins
identified in our study seem to be implicated in stress response. In this respect, it would be interesting
to explore the potential correlation between the expression of T3SS effector proteins and response to
stress conditions. These secreted proteins being very important in the molecular interplay between
bacteria and host cells, they deserve a particular interest in the context of nutrient acquisition as well
as persistence of Chlamydiales bacteria.
To conclude, this work reports a screening for secreted proteins of C. trachomatis and W. chondrophila
using PFO to gain access to the protein content of infected cells cytosol. This screening enabled the
identification of several interesting C. trachomatis putative effectors potentially involved in chromatin
remodelling or in responses to stressful conditions. In addition, we also shed light on two W. chondrophila
T3SS effectors, Wcw_0499 and Wcw_1706 that are implicated in the early to mid-stages of infection.
Determining the cellular pathways targeted by these proteins will certainly help understanding the
different strategies evolved by Chlamydiales bacteria to survive in their diverse environments.
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